Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 2025 Outlook

<< Previous

Bullboard Posts

Next >>

Comment by bmk211on Nov 19, 2024 11:22pm

236 Views

Post# 36320986

RE:RE:2025 Outlook

I am holding 25,000 shares. Probably nothing compared to you all. But this is my first investment as someone I know who is close to me has bladder cancer. But seriously $100/share that is a bit extreme right? Would there need to be a theralase clinic on every stretch corner for that to happen? What's a hypothetical path of how the stock would ever go that high?

I saw bright minds biosciences (DRUG) stock skyrocket and I'm still a little perplexed by that.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments